Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)

Recombinant Respiratory Syncytial Virus Vaccine · MAXVAX Biotechnology Limited Liability Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell), covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) [Phase 3]

See pricing